Our Recommendations
New Publications
- NTDs Part 1: Buruli Ulcer, Chagas, Leishmaniasis (2024)
- Leishmaniasis (2023)
- Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)
- WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia (2022)
- Cutaneous Leishmaniasis: Urgent need to develop more effective and user-friendly point-of-care diagnostic tools (2022)
Filter
32
Featured
Recommendations
2
New Publications
2
Language
Document type
Studies & Reports
11
Guidelines
7
Fact sheets
6
Strategic & Response Plan
3
No document type
3
Training Material
1
Resource Platforms
1
Countries / Regions
Global
15
Latin America and the Carribbean
9
Middle East and North Africa
4
Sudan
4
Asia
3
Brazil
3
Ethiopia
3
South Sudan
3
India
3
Kenya
2
South–East Asia Region
2
East and Southern Africa
2
Bangladesh
2
Greece
2
Somalia
2
Nepal
1
Colombia
1
Mexico
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Senegal
1
Morocco
1
Africa
1
Jordan
1
Saudi Arabia
1
West and Central Africa
1
Western and Central Europe
1
Paraguay
1
North America
1
Tunisia
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Georgia
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
32
Disease Prevention & Control
15
Guidelines
5
Health System Strengthening
3
Pharmacy & Technologies
3
Vector Control
2
Studies & Reports
2
NTDs & Others
2
Parasitology
2
Helminthiasis
1
Buruli Ulcer
1
Gender
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Chagas
1
Human African Trypanosomiasis
1
Toolboxes
Leishmaniasis
17
Studies & Reports
11
Vector control
5
Statistics & Facts
4
NTDs General
4
Overview, Studies & Reports
4
Clinical Aspects & Diagnostics
3
Opportunistic Infections
1
Pharmacy
1
Essential Medicines
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Statistics & Facts
1
Information & Education Material (IEC)
1
his first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
Leishmaniose cutanée : un important problèmede santé
La leishmaniose cutanée est une maladie potentiellement grave et défigurante. Les personnes atteintes de leishmaniose cutanée ont une ou plusieurs lésions durables sur la peau, le plus souvent sans fièvre ni symptômes généraux. L'impac...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and...
Leishmaniasis is a parasitic disease caused by the Leishmania parasite. This parasite typically lives in infected sand flies. You can contract leishmaniasis from a bite of an infected sand fly.
The sand flies that carry the parasite typically reside in tropical and subtropical environments. Fatal...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600...
Leishmaniasis is a parasitic disease caused by intracellular protozoan parasites of the genus Leishmania (Trypanosomatidae family); it is endemic in more than 98 countries worldwide [1]. Visceral (VL) and cutaneous (CL) leishmaniasis are the most common forms of the disease. VL causes a systemic dis...
Leishmaniasis is an infection caused by the Leishmania parasites. The infection is transmitted by the bite of infected phlebotomine sandfly. There are over 20 types of Leishmania parasites which cause infection in people and 30 different types of sand flies to spread infection. Leishmaniasis is wide...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
More than one million people each year become infected by parasites that cause the disease cutaneous leishmaniasis (CL). This disease manifests as one or more skin lesions or ulcers that are slow to heal with variable response rates to drug treatments. Thus far, little attention has been paid to how...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Leishmaniasis is a spectrum of disease caused by the infection of protozoan parasite Leishmania mainly affecting the antigen presenting cell of the host. The disease is although considered as neglected tropical disease still it is not completely eradicated. Majority of the issues related to the ther...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife...
Guillain-Barre Syndrome (GBS) is an acute autoimmune polyradiculoneuropathy that often follows an antecedent infection. Leishmaniasis is a zoonosis due to a flagellate protozoan of the Leishmania genus and transmitted by the sandfly. Here we report a 15 years old teenager who presented with an ascen...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
No vaccines or drugs to prevent infection are available. The best way for travelers to prevent infection is to protect themselves from sand fly bites. To decrease the risk of being bitten, follow these preventive measures:
Avoid outdoor activities, especially from dusk to dawn, when sand flies ge...
The results of a large-scale systematic review and meta-analysis have published in PLOS Neglected Tropical Diseases. This research aimed to collate all reported serious adverse events (SAE) in visceral leishmaniasis (VL) clinical trials and quantify the incidence of mortality during the first 30 day...
MEDBOX Issue Brief no.35: The first issue brief on the NTD Toolbox contains general strategies, roadmaps, key treatment guidelines, reports, and training material on Buruli ulcer, Chagas, and Leishmaniasis.
